SANUWAVE Health, Inc.
SNWV
$28.00
-$1.98-6.60%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 32.63M | 29.30M | 24.90M | 22.41M | 20.40M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.63M | 29.30M | 24.90M | 22.41M | 20.40M |
| Cost of Revenue | 8.08M | 7.96M | 7.08M | 6.36M | 6.04M |
| Gross Profit | 24.55M | 21.34M | 17.82M | 16.05M | 14.36M |
| SG&A Expenses | 17.67M | 15.99M | 14.96M | 14.31M | 13.57M |
| Depreciation & Amortization | 789.00K | 757.00K | 738.00K | 745.00K | 752.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.22M | 25.37M | 23.45M | 22.02M | 20.94M |
| Operating Income | 5.42M | 3.93M | 1.45M | 389.00K | -539.00K |
| Income Before Tax | -31.35M | -385.00K | -3.43M | -17.25M | -25.80M |
| Income Tax Expenses | 27.00K | 4.00K | 4.00K | 4.00K | 4.00K |
| Earnings from Continuing Operations | -31.37 | -0.39 | -3.43 | -17.26 | -25.81 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31.37M | -389.00K | -3.43M | -17.26M | -25.81M |
| EBIT | 5.42M | 3.93M | 1.45M | 389.00K | -539.00K |
| EBITDA | 6.56M | 4.92M | 2.44M | 1.38M | 489.00K |
| EPS Basic | -7.38 | 0.21 | -3.25 | -10.01 | -17.08 |
| Normalized Basic EPS | -5.73 | -0.90 | -3.06 | -6.23 | -10.67 |
| EPS Diluted | -7.69 | -0.09 | -3.56 | -10.01 | -17.08 |
| Normalized Diluted EPS | -5.76 | -0.93 | -3.10 | -6.23 | -10.67 |
| Average Basic Shares Outstanding | 17.85M | 12.44M | 11.63M | 10.03M | 8.47M |
| Average Diluted Shares Outstanding | 18.40M | 12.98M | 12.18M | 10.03M | 8.47M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |